Mesothelioma peritoneal cancer treatment and cancer of the lining of the abdominal cavity is the peritoneal mesothelioma. It is not as common as pleural form, comprising about one-fifth to one-third of all mesothelioma cases diagnosed. This report on the results of the surveillance, epidemiology and end the number closer to 54% men and 45% of women, ranging in age from 65 to 69 with the symptoms of peritoneal mesothelioma abdominal masspain abdominal pain, abdomen distension and more fluids abdominalcavity the distension of the abdomens and weight loss, fever,orfatigue and digestive problems.Latency is shorter for patients who asbestos, 20-30 years of exposurethe latency period of pleural mesothelioma in the years 30-40.
Peritoneal mesothelioma symptoms
A few months before the diagnosis is confirmed, although some patients complain of symptoms are not specific. Furthermore, peritoneal mesothelioma in some cases when the patient has other issues, such as hernias, gall bladder or pelvic mass.
The doctors, who have experience in this field have noted that patients often have symptoms for six months to two years before diagnosis. Men often complain that doctors swelling in the groin (hernia) or around the navel (umbilical hernia). such as "dry" and "wet". It is classified as "dry" when there are multiple small masses or a localized mass of dominant and ascites is moderate or not.For women the first sign of a problem in the basin is often tested when the tumor was found.
The diagnosis of peritoneal mesothelioma
Peritoneal mesothelioma has two clinical types can be differentiated by the results of the analysis, The "wet" type, there is a small nodules common, no dominant mass, and the presence of ascites.
If the liquid is detected, the process of elimination by paracentesis, but the analysis of this liquid has a limited role in diagnosis. Generally, the final diagnosis obtained by tissue biopsy.
Staging As there is currently no transit system for peritoneal mesothelioma, the most important system for cancer staging general (TNM) is used. TNM system has the following criteria: (a) the status of cancer, (N), lymph nodes, and (M) metastases. Other general categories may also be useful to find on stage.
Class 1, 2, 3 and 4 as follows in a local lesion that can be completely removed (resection)located inside the peritoneal cavity of peritoneal and organ surfaces, where there is a chance to remove as much tumor as possibl , found in the abdominal cavity and invaded organs like the liver or colon and finallyextending into the abdominal cavity.Treatment of these intenal peritoneal mesothelioma
Lately, the effectiveness of surgery alone or intraperitoneal chemotherapy for the treatment of peritoneal mesothelioma has not been proved, therefore, multimodal therapy is becoming increasingly popular. Reduction surgery (debulking) surgery is to remove all or nearly all the visible tumor and can be combined with IPHC (intraperitoneal hyper-thermal chemotherapy), chemotherapy and radiation therapy to the abdomen.
Removal of all cancers are not always possible, the prognosis of survival in all cytoreduction may be followed by establishing the following criteria:
Complete cytoreduction
CC-0-3: No peritoneal seeding, smaller then 2.5 cm entered following cytoreduction by chemo intra-cavity, so the process is called complete, incomplete cytoreduction lumpsbetween 2.5 to 5 cm, and then continues cytoreductionnodules > 5 cm or not a merger of tumor nodules that aren'toperable at in the pelvis or abdomen.
Some patients may have a common disease in which surgery is not considered "potentially curative" palliative care can make the tumor shrink. recent clinical study of ALIMTA (pemetrexed) to function as effective chemotherapy for the treatment of peritoneal mesothelioma, alone or in combination with cisplatin or platinum-based drugs. This reflects previous findings on drugs in pleural mesothelioma, pemetrexed.Note that care is a physician experienced in peritoneal mesothelioma is a rare malignant.
